D. Accili

Molecular Biology · 2002–2021

A researcher in the Science corpus: 14 papers; trusts 4 researchers and is trusted by 13 researchers here, as inferred from the citation graph.

Subfields

• Molecular Biology — 150 citations into it; #4,267 of 17,773 by trust here, #2,290 by citations
• Surgery — 56 citations into it
• Geriatrics and Gerontology — 24 citations into it; #41 of 114 by trust here, #51 by citations
• Aging — 17 citations into it; #88 of 261 by trust here, #119 by citations
• Genetics — 15 citations into it

Whom D. Accili trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

1. J. Seoane
2. M. Fulco
3. M. Sandri
4. T. Kitamura
5. P. Puigserver
6. C. Sandri
7. K. Arden

Who trusts D. Accili overall

1. J. Massagué
2. Maria K. Lehtinen
3. S. Manolagas
4. Douglas C. Wallace
5. David H. Gross
6. M. Haigis
7. M. Matsumoto
8. R. Shaw
9. Lewis C. Cantley
10. Zengqiang Yuan

Papers from D. Accili's perspective

Ordered by how strongly the researchers D. Accili trusts endorse each paper. Same corpus, a different order for every researcher.

1. New perspectives into the molecular pathogenesis and treatment of type 2 diabetes. (Cell)
2. Sir2 regulates skeletal muscle differentiation as a potential sensor of the redox state. (Molecules and Cells)
3. Sirt1 promotes fat mobilization in white adipocytes by repressing PPAR-γ (Nature)
4. Calorie Restriction Promotes Mammalian Cell Survival by Inducing the SIRT1 Deacetylase (Science)
5. Integration of Smad and forkhead pathways in the control of neuroepithelial and glioblastoma cell proliferation. (Cell)
6. AFX-like Forkhead transcription factors mediate cell-cycle regulation by Ras and PKB through p27kip1 (Nature)
7. FoxOs at the crossroads of cellular metabolism, differentiation, and transformation. (Cell)
8. Mammalian sirtuins--emerging roles in physiology, aging, and calorie restriction. (Genes & Development)
9. FoxO1 protects against pancreatic beta cell failure through NeuroD and MafA induction. (Cell Metabolism)
10. Increased dosage of mammalian Sir2 in pancreatic beta cells enhances glucose-stimulated insulin secretion in mice. (Cell Metabolism)

Their papers

• Structure-based prediction of protein-protein interactions on a genome-wide scale (2012) — 685 citations
• FoxOs at the crossroads of cellular metabolism, differentiation, and transformation. (2004) — 1,390 citations
• Insulin-regulated hepatic gluconeogenesis through FOXO1–PGC-1α interaction (2003) — 1,372 citations
• The forkhead transcription factor Foxo1 regulates adipocyte differentiation. (2003) — 747 citations
• Regulation of insulin action and pancreatic β-cell function by mutated alleles of the gene encoding forkhead transcription factor Foxo1 (2002) — 662 citations
• Pancreatic β-Cell Dedifferentiation As Mechanism Of Diabetic β-Cell Failure (2012) — 1,267 citations
• FoxO1 protects against pancreatic beta cell failure through NeuroD and MafA induction. (2005) — 601 citations
• Impaired regulation of hepatic glucose production in mice lacking the forkhead transcription factor Foxo1 in liver. (2007) — 600 citations
• Post-acute COVID-19 syndrome (2021) — 4,179 citations
• Extrapulmonary manifestations of COVID-19 (2020) — 2,748 citations
• Biochemical and cellular properties of insulin receptor signalling (2017) — 623 citations
• Brown Remodeling of White Adipose Tissue by SirT1-Dependent Deacetylation of Pparγ (2012) — 792 citations
• SirT1 gain-of-function increases energy efficiency and prevents diabetes in mice (2008) — 659 citations
• Insulin-regulated hepatic gluconeogenesis through FOXO1-PGC-1alpha interaction. (2003) — 713 citations